RightBio Metrics, a company out of Scottsdale, Arizona, received both FDA and CE Mark approvals and is launching three new products for safe placement of nasogastric tubes and measurement of gastric pH levels. These include the RightSpot pH Indicator, RightSpot Infant pH Indicator, and RightLevel pH Detector, all three designed to increase safety, improve reading accuracy, and do it in a cleaner fashion.
The RightSpot pH and RightSpot Infant pH Indicators are non-invasive devices for verifying gastric acidity in order to avoid improper positioning of nasogastric and percutaneous endoscopic gastrostomy tubes. The RightLevel pH Detector is indicated for measuring pH levels in the stomachs of critically ill patients.
From the announcement:
All three products have received CLIA Waived status, which means the FDA has classified them as simple laboratory examinations and procedures that have an insignificant risk of an erroneous result, which makes it easier for hospitals to perform onsite and maintain per CAP regulations.
“As an emergency room physician, I experienced firsthand the devastating effects of improper NG tube placement and uncertainty about treatment-critical metrics due to antiquated technology. Seeing patients put at unnecessary risk ignited my passion to make much needed fluid measurement technology improvements,” said Paul Gilbert, MD, co-founder and president, RightBio Metrics.
Company video presenting the RightSpot:
Here’s one about the RightLevel:
Link: RightpH products…